PRESS RELEASE
inSeption Group Named One of Philadelphia’s Fastest-Growing Companies in 2024 by Philadelphia Business Journal [Lansdale,... Continue reading→
PRESS RELEASE
inSeption Group Co-Founders and Managing Partners Joe Arcangelo and Brian Sulpizio Named as EY Entrepreneurs... Continue reading→
PRESS RELEASE
inSeption Group Named a Best Places to Work Finalist by Philadelphia Business Journal for Second... Continue reading→
PRESS RELEASE
inSeption Group’s Executive Vice President, is elected Chair-Elect of the Council on Professional Registration for... Continue reading→
inSpired by Danielle Starke
Spotlight on Danielle Starke, Clinical Manager and Camp One Step Danielle Starke has long known... Continue reading→
Scaling Phase III Studies
What Big CROs Don't Want You To Know About Staffing Scalability For Phase III Studies... Continue reading→
Philadelphia Business Journal 2023 Best Places to Work: inSeption Group
inSeption Group Recognized Among Philadelphia Business Journal’s 2023 Best Places to Work inSeption Group has... Continue reading→
Mock Inspection Challenge Solution
At inSeption Group, we can effectively prepare your company for FDA approval and inspection. We... Continue reading→
Navigating the Trials of Clinical Research
Navigating the Trials of Clinical Research
Investing in Upfront Communication For An Effective Relationship
In a recent newsletter, Joseph Arcangelo, the Co-Founder and Managing Partner of inSeption Group, speaks... Continue reading→
Multitherapeutic Contract Research Partners: Are They Right For You?
Multitherapeutic contract research partners can promise a great deal to their potential clients—access to vast... Continue reading→
